Protective effect of histone methyltransferase NSD3 on ISO-induced cardiac hypertrophy

被引:9
作者
Chen, Ke [1 ,2 ]
Jian, Dongdong [1 ,2 ]
Zhao, Linwei [1 ,2 ]
Zang, Xiaobiao [1 ,2 ]
Song, Weifeng [1 ,2 ]
Ma, Jifang [1 ,2 ]
Jia, Zhen [3 ]
Wang, Xianqing [1 ,2 ]
Gao, Chuanyu [1 ,2 ]
机构
[1] Fuwai Cent China Cardiovasc Hosp, Dept Cardiol, Zhengzhou 450000, Henan, Peoples R China
[2] Henan Prov Peoples Hosp, Zhengzhou 450000, Henan, Peoples R China
[3] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiothorac Surg, Hangzhou, Zhejiang, Peoples R China
关键词
ANF; BRD4; cardiomyocyte hypertrophy; H3K27ac; H3K27me2/3; NSD3; DOMAIN; ACTIVATION; REGRESSION; PROTEINS; HEART; BRD4;
D O I
10.1002/1873-3468.13515
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear receptor-binding SET domain 3 (NSD3) is a lysine methyltransferase that plays important roles in multiple biological activities; however; its potential roles in the cardiovascular system remain unknown. In this study, we found that NSD3 expression is reduced by isoproterenol (ISO) stimuli both in vitro and in vivo. Overexpression of NSD3 attenuates ISO-induced cardiomyocyte hypertrophy. Mechanistically, ISO treatment decreases H3K27me2/3 modifications on the atrial natriuretic factor (ANF) promoter by suppressing NSD3 and inhibits the association between NSD3 and bromodomain-containing protein 4 (BRD4), thus suppressing the BRD4-mediated H3K27ac modifications, which ultimately promote ANF transcription and cardiomyocyte hypertrophy. In conclusion, NSD3 decreases ANF expression and, thereby, attenuates ISO-induced cardiomyocyte hypertrophy.
引用
收藏
页码:2556 / 2565
页数:10
相关论文
共 23 条
[1]   C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure [J].
Appari, Mahesh ;
Breitbart, Astrid ;
Brandes, Florian ;
Szaroszyk, Malgorzata ;
Froese, Natali ;
Korf-Klingebiel, Mortimer ;
Mohammadi, Mona Malek ;
Grund, Andrea ;
Scharf, Gesine M. ;
Wang, Honghui ;
Zwadlo, Carolin ;
Fraccarollo, Daniela ;
Schrameck, Ulrike ;
Nemer, Mona ;
Wong, G. William ;
Katus, Hugo A. ;
Wollert, Kai C. ;
Mueller, Oliver J. ;
Bauersachs, Johann ;
Heineke, Joerg .
CIRCULATION RESEARCH, 2017, 120 (01) :66-+
[2]   PHD fingers in human diseases: Disorders arising from misinterpreting epigenetic marks [J].
Baker, Lindsey A. ;
Allis, C. David ;
Wang, Gang G. .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2008, 647 (1-2) :3-12
[3]   Overexpression of SARAF Ameliorates Pressure Overload-Induced Cardiac Hypertrophy Through Suppressing STIM1-Orai1 in Mice [J].
Dai, Fengdan ;
Zhang, Yan ;
Wang, Qiang ;
Li, De ;
Yang, Yongjian ;
Ma, Shuangtao ;
Yang, Dachun .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (02) :817-826
[4]   Targeting Transmembrane BAX Inhibitor Motif Containing 1 Alleviates Pathological Cardiac Hypertrophy [J].
Deng, Ke-Qiong ;
Zhao, Guang-Nian ;
Wang, Zhihua ;
Fang, Jing ;
Jiang, Zhou ;
Gong, Jun ;
Yan, Feng-Juan ;
Zhu, Xue-Yong ;
Zhang, Peng ;
She, Zhi-Gang ;
Li, Hongliang .
CIRCULATION, 2018, 137 (14) :1486-1504
[5]   The SET-domain protein superfamily: protein lysine methyltransferases [J].
Dillon, SC ;
Zhang, X ;
Trievel, RC ;
Cheng, XD .
GENOME BIOLOGY, 2005, 6 (08)
[6]   Regression of pathological cardiac hypertrophy: Signaling pathways and therapeutic targets [J].
Hou, Jianglong ;
Kang, Y. James .
PHARMACOLOGY & THERAPEUTICS, 2012, 135 (03) :337-354
[7]   Interferon-induced protein 35 inhibits endothelial cell proliferation, migration and re-endothelialization of injured arteries by inhibiting the nuclear factor-kappa B pathway [J].
Jian, D. ;
Wang, W. ;
Zhou, X. ;
Jia, Z. ;
Wang, J. ;
Yang, M. ;
Zhao, W. ;
Jiang, Z. ;
Hu, X. ;
Zhu, J. .
ACTA PHYSIOLOGICA, 2018, 223 (03)
[8]   ZFP260 Is an Inducer of Cardiac Hypertrophy and a Nuclear Mediator of Endothelin-1 Signaling [J].
Komati, Hiba ;
Maharsy, Wael ;
Beauregard, Janie ;
Hayek, Salim ;
Nemer, Mona .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (02) :1508-1516
[9]   Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril [J].
Mathew, J ;
Sleight, P ;
Lonn, E ;
Johnstone, D ;
Pogue, J ;
Yi, QL ;
Bosch, J ;
Sussex, B ;
Probstfield, J ;
Yusuf, S .
CIRCULATION, 2001, 104 (14) :1615-1621
[10]   Nicorandil enhances the efficacy of mesenchymal stem cell therapy in isoproterenol-induced heart failure in rats [J].
Mohamed, Sarah S. ;
Ahmed, Lamiaa A. ;
Attia, Wael A. ;
Khattab, Mahmoud M. .
BIOCHEMICAL PHARMACOLOGY, 2015, 98 (03) :403-411